Label: LBEL CLARITE CLARIFYING EFFECT FOUNDATION SPF 30 CLAIRE 1/BEIGE- octinoxate and zinc oxide liquid
LBEL CLARITE CLARIFYING EFFECT FOUNDATION SPF 30 CLAIRE 2/BEIGE- octinoxate and zinc oxide liquid
LBEL CLARITE CLARIFYING EFFECT FOUNDATION SPF 30 CLAIRE 3/BEIGE- octinoxate and zinc oxide liquid
LBEL CLARITE CLARIFYING EFFECT FOUNDATION SPF 30 CLAIRE 4/BEIGE- octinoxate and zinc oxide liquid
LBEL CLARITE CLARIFYING EFFECT FOUNDATION SPF 30 CLAIRE 5/BEIGE- octinoxate and zinc oxide liquid
LBEL CLARITE CLARIFYING EFFECT FOUNDATION SPF 30 CLAIRE 6/BEIGE- octinoxate and zinc oxide liquid
LBEL CLARITE CLARIFYING EFFECT FOUNDATION SPF 30 CLAIRE 7/BEIGE- octinoxate and zinc oxide liquid
LBEL CLARITE CLARIFYING EFFECT FOUNDATION SPF 30 CLAIRE 8/BEIGE- octinoxate and zinc oxide liquid
LBEL CLARITE CLARIFYING EFFECT FOUNDATION SPF 30 CLAIRE 9/BROWN- octinoxate and zinc oxide liquid
-
Contains inactivated NDC Code(s)
NDC Code(s): 14783-213-01, 14783-213-02, 14783-214-01, 14783-214-02, view more14783-215-01, 14783-215-02, 14783-216-01, 14783-216-02, 14783-217-01, 14783-217-02, 14783-218-01, 14783-218-02, 14783-219-01, 14783-219-02, 14783-220-01, 14783-220-02, 14783-221-01, 14783-221-02 - Packager: Ventura International LTD
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: OTC monograph final
DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Drug Label Information
Updated December 20, 2018
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- SPL UNCLASSIFIED SECTION
- ACTIVE INGREDIENT
- Uses
- Warnings
- Directions
- Other information
-
Inactive ingredients
Dimethicone, mica, zea mays (corn) starch, ozokerite, polyethylene, silica dimethyl silylate, peg/ppg-18/18 dimethicone, copernicia cerifera (carnauba) wax, kojic dipalmitate, cetyl peg/ppg-10/1 dimethicone, polyglyceryl-4 isostearate, hexyl laurate, phenoxyethanol, triethoxycaprylylsilane, caprylyl glycol, chlorphenesin, fragrante, glycyrrhiza glabra (licorice) root extract, trimethylsiloxysilicate, dimethylmethoxy chromanyl palmitato, citronellol, butylphenyl methylpropional, hydroxycitronellal, hexyl cinnamal, d-limonene, hydroxyisohexyl 3-cyclohexene carboxaldehyde, alpha-isomethyl ionone.
May Contain: titanium dioxide, iron oxides.
- SPL UNCLASSIFIED SECTION
- PRINCIPAL DISPLAY PANEL - 9 g Container Box - Claire 1/Beige
- PRINCIPAL DISPLAY PANEL - 9 g Container Box - Claire 2/Beige
- PRINCIPAL DISPLAY PANEL - 9 g Container Box - Claire 3/Beige
- PRINCIPAL DISPLAY PANEL - 9 g Container Box - Claire 4/Beige
- PRINCIPAL DISPLAY PANEL - 9 g Container Box - Claire 5/Beige
- PRINCIPAL DISPLAY PANEL - 9 g Container Box - Claire 6/Beige
- PRINCIPAL DISPLAY PANEL - 9 g Container Box - Claire 7/Beige
- PRINCIPAL DISPLAY PANEL - 9 g Container Box - Claire 8/Beige
- PRINCIPAL DISPLAY PANEL - 9 g Container Box - Claire 9/Brown
-
INGREDIENTS AND APPEARANCE
LBEL CLARITE CLARIFYING EFFECT FOUNDATION SPF 30 CLAIRE 1/BEIGE
octinoxate and zinc oxide liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:14783-213 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 0.075 g in 1 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 0.0784 g in 1 g Inactive Ingredients Ingredient Name Strength Dimethicone (UNII: 92RU3N3Y1O) mica (UNII: V8A1AW0880) starch, corn (UNII: O8232NY3SJ) high density polyethylene (UNII: UG00KM4WR7) silica dimethyl silylate (UNII: EU2PSP0G0W) peg/ppg-18/18 dimethicone (UNII: 9H0AO7T794) carnauba wax (UNII: R12CBM0EIZ) kojic dipalmitate (UNII: 13N249RWTM) polyglyceryl-4 isostearate (UNII: 820DPX33S7) hexyl laurate (UNII: 4CG9F9W01Q) phenoxyethanol (UNII: HIE492ZZ3T) triethoxycaprylylsilane (UNII: LDC331P08E) caprylyl glycol (UNII: 00YIU5438U) chlorphenesin (UNII: I670DAL4SZ) licorice (UNII: 61ZBX54883) dimethylmethoxy chromanyl palmitate (UNII: 5G222ZDK7U) .beta.-citronellol, (R)- (UNII: P01OUT964K) butylphenyl methylpropional (UNII: T7540GJV69) hydroxycitronellal (UNII: 8SQ0VA4YUR) .alpha.-hexylcinnamaldehyde (UNII: 7X6O37OK2I) limonene, (+)- (UNII: GFD7C86Q1W) hydroxyisohexyl 3-cyclohexene carboxaldehyde (UNII: QUE43B9Z2Q) isomethyl-.alpha.-ionone (UNII: 9XP4LC555B) titanium dioxide (UNII: 15FIX9V2JP) ferric oxide red (UNII: 1K09F3G675) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:14783-213-02 1 in 1 BOX 12/26/2018 1 NDC:14783-213-01 9 g in 1 CONTAINER; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 12/26/2018 LBEL CLARITE CLARIFYING EFFECT FOUNDATION SPF 30 CLAIRE 2/BEIGE
octinoxate and zinc oxide liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:14783-214 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 0.075 g in 1 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 0.0784 g in 1 g Inactive Ingredients Ingredient Name Strength Dimethicone (UNII: 92RU3N3Y1O) mica (UNII: V8A1AW0880) starch, corn (UNII: O8232NY3SJ) high density polyethylene (UNII: UG00KM4WR7) silica dimethyl silylate (UNII: EU2PSP0G0W) peg/ppg-18/18 dimethicone (UNII: 9H0AO7T794) carnauba wax (UNII: R12CBM0EIZ) kojic dipalmitate (UNII: 13N249RWTM) polyglyceryl-4 isostearate (UNII: 820DPX33S7) hexyl laurate (UNII: 4CG9F9W01Q) phenoxyethanol (UNII: HIE492ZZ3T) triethoxycaprylylsilane (UNII: LDC331P08E) caprylyl glycol (UNII: 00YIU5438U) chlorphenesin (UNII: I670DAL4SZ) licorice (UNII: 61ZBX54883) dimethylmethoxy chromanyl palmitate (UNII: 5G222ZDK7U) .beta.-citronellol, (R)- (UNII: P01OUT964K) butylphenyl methylpropional (UNII: T7540GJV69) hydroxycitronellal (UNII: 8SQ0VA4YUR) .alpha.-hexylcinnamaldehyde (UNII: 7X6O37OK2I) limonene, (+)- (UNII: GFD7C86Q1W) hydroxyisohexyl 3-cyclohexene carboxaldehyde (UNII: QUE43B9Z2Q) isomethyl-.alpha.-ionone (UNII: 9XP4LC555B) titanium dioxide (UNII: 15FIX9V2JP) ferric oxide red (UNII: 1K09F3G675) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:14783-214-02 1 in 1 BOX 12/26/2018 1 NDC:14783-214-01 9 g in 1 CONTAINER; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 12/26/2018 LBEL CLARITE CLARIFYING EFFECT FOUNDATION SPF 30 CLAIRE 3/BEIGE
octinoxate and zinc oxide liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:14783-215 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 0.075 g in 1 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 0.0784 g in 1 g Inactive Ingredients Ingredient Name Strength Dimethicone (UNII: 92RU3N3Y1O) mica (UNII: V8A1AW0880) starch, corn (UNII: O8232NY3SJ) high density polyethylene (UNII: UG00KM4WR7) silica dimethyl silylate (UNII: EU2PSP0G0W) peg/ppg-18/18 dimethicone (UNII: 9H0AO7T794) carnauba wax (UNII: R12CBM0EIZ) kojic dipalmitate (UNII: 13N249RWTM) polyglyceryl-4 isostearate (UNII: 820DPX33S7) hexyl laurate (UNII: 4CG9F9W01Q) phenoxyethanol (UNII: HIE492ZZ3T) triethoxycaprylylsilane (UNII: LDC331P08E) caprylyl glycol (UNII: 00YIU5438U) chlorphenesin (UNII: I670DAL4SZ) licorice (UNII: 61ZBX54883) dimethylmethoxy chromanyl palmitate (UNII: 5G222ZDK7U) .beta.-citronellol, (R)- (UNII: P01OUT964K) butylphenyl methylpropional (UNII: T7540GJV69) hydroxycitronellal (UNII: 8SQ0VA4YUR) .alpha.-hexylcinnamaldehyde (UNII: 7X6O37OK2I) limonene, (+)- (UNII: GFD7C86Q1W) hydroxyisohexyl 3-cyclohexene carboxaldehyde (UNII: QUE43B9Z2Q) isomethyl-.alpha.-ionone (UNII: 9XP4LC555B) titanium dioxide (UNII: 15FIX9V2JP) ferric oxide red (UNII: 1K09F3G675) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:14783-215-02 1 in 1 BOX 12/26/2018 1 NDC:14783-215-01 9 g in 1 CONTAINER; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 12/26/2018 LBEL CLARITE CLARIFYING EFFECT FOUNDATION SPF 30 CLAIRE 4/BEIGE
octinoxate and zinc oxide liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:14783-217 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 0.075 g in 1 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 0.0784 g in 1 g Inactive Ingredients Ingredient Name Strength Dimethicone (UNII: 92RU3N3Y1O) mica (UNII: V8A1AW0880) starch, corn (UNII: O8232NY3SJ) high density polyethylene (UNII: UG00KM4WR7) silica dimethyl silylate (UNII: EU2PSP0G0W) peg/ppg-18/18 dimethicone (UNII: 9H0AO7T794) carnauba wax (UNII: R12CBM0EIZ) kojic dipalmitate (UNII: 13N249RWTM) polyglyceryl-4 isostearate (UNII: 820DPX33S7) hexyl laurate (UNII: 4CG9F9W01Q) phenoxyethanol (UNII: HIE492ZZ3T) triethoxycaprylylsilane (UNII: LDC331P08E) caprylyl glycol (UNII: 00YIU5438U) chlorphenesin (UNII: I670DAL4SZ) licorice (UNII: 61ZBX54883) dimethylmethoxy chromanyl palmitate (UNII: 5G222ZDK7U) .beta.-citronellol, (R)- (UNII: P01OUT964K) butylphenyl methylpropional (UNII: T7540GJV69) hydroxycitronellal (UNII: 8SQ0VA4YUR) .alpha.-hexylcinnamaldehyde (UNII: 7X6O37OK2I) limonene, (+)- (UNII: GFD7C86Q1W) hydroxyisohexyl 3-cyclohexene carboxaldehyde (UNII: QUE43B9Z2Q) isomethyl-.alpha.-ionone (UNII: 9XP4LC555B) titanium dioxide (UNII: 15FIX9V2JP) ferric oxide red (UNII: 1K09F3G675) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:14783-217-02 1 in 1 BOX 12/26/2018 1 NDC:14783-217-01 9 g in 1 CONTAINER; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 12/26/2018 LBEL CLARITE CLARIFYING EFFECT FOUNDATION SPF 30 CLAIRE 5/BEIGE
octinoxate and zinc oxide liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:14783-218 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 0.075 g in 1 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 0.0784 g in 1 g Inactive Ingredients Ingredient Name Strength Dimethicone (UNII: 92RU3N3Y1O) mica (UNII: V8A1AW0880) starch, corn (UNII: O8232NY3SJ) high density polyethylene (UNII: UG00KM4WR7) silica dimethyl silylate (UNII: EU2PSP0G0W) peg/ppg-18/18 dimethicone (UNII: 9H0AO7T794) carnauba wax (UNII: R12CBM0EIZ) kojic dipalmitate (UNII: 13N249RWTM) polyglyceryl-4 isostearate (UNII: 820DPX33S7) hexyl laurate (UNII: 4CG9F9W01Q) phenoxyethanol (UNII: HIE492ZZ3T) triethoxycaprylylsilane (UNII: LDC331P08E) caprylyl glycol (UNII: 00YIU5438U) chlorphenesin (UNII: I670DAL4SZ) licorice (UNII: 61ZBX54883) dimethylmethoxy chromanyl palmitate (UNII: 5G222ZDK7U) .beta.-citronellol, (R)- (UNII: P01OUT964K) butylphenyl methylpropional (UNII: T7540GJV69) hydroxycitronellal (UNII: 8SQ0VA4YUR) .alpha.-hexylcinnamaldehyde (UNII: 7X6O37OK2I) limonene, (+)- (UNII: GFD7C86Q1W) hydroxyisohexyl 3-cyclohexene carboxaldehyde (UNII: QUE43B9Z2Q) isomethyl-.alpha.-ionone (UNII: 9XP4LC555B) titanium dioxide (UNII: 15FIX9V2JP) ferric oxide red (UNII: 1K09F3G675) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:14783-218-02 1 in 1 BOX 12/26/2018 1 NDC:14783-218-01 9 g in 1 CONTAINER; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 12/26/2018 LBEL CLARITE CLARIFYING EFFECT FOUNDATION SPF 30 CLAIRE 6/BEIGE
octinoxate and zinc oxide liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:14783-219 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 0.075 g in 1 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 0.0784 g in 1 g Inactive Ingredients Ingredient Name Strength Dimethicone (UNII: 92RU3N3Y1O) mica (UNII: V8A1AW0880) starch, corn (UNII: O8232NY3SJ) high density polyethylene (UNII: UG00KM4WR7) silica dimethyl silylate (UNII: EU2PSP0G0W) peg/ppg-18/18 dimethicone (UNII: 9H0AO7T794) carnauba wax (UNII: R12CBM0EIZ) kojic dipalmitate (UNII: 13N249RWTM) polyglyceryl-4 isostearate (UNII: 820DPX33S7) hexyl laurate (UNII: 4CG9F9W01Q) phenoxyethanol (UNII: HIE492ZZ3T) triethoxycaprylylsilane (UNII: LDC331P08E) caprylyl glycol (UNII: 00YIU5438U) chlorphenesin (UNII: I670DAL4SZ) licorice (UNII: 61ZBX54883) dimethylmethoxy chromanyl palmitate (UNII: 5G222ZDK7U) .beta.-citronellol, (R)- (UNII: P01OUT964K) butylphenyl methylpropional (UNII: T7540GJV69) hydroxycitronellal (UNII: 8SQ0VA4YUR) .alpha.-hexylcinnamaldehyde (UNII: 7X6O37OK2I) limonene, (+)- (UNII: GFD7C86Q1W) hydroxyisohexyl 3-cyclohexene carboxaldehyde (UNII: QUE43B9Z2Q) isomethyl-.alpha.-ionone (UNII: 9XP4LC555B) titanium dioxide (UNII: 15FIX9V2JP) ferric oxide red (UNII: 1K09F3G675) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:14783-219-02 1 in 1 BOX 12/26/2018 1 NDC:14783-219-01 9 g in 1 CONTAINER; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 12/26/2018 LBEL CLARITE CLARIFYING EFFECT FOUNDATION SPF 30 CLAIRE 7/BEIGE
octinoxate and zinc oxide liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:14783-220 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 0.075 g in 1 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 0.0784 g in 1 g Inactive Ingredients Ingredient Name Strength Dimethicone (UNII: 92RU3N3Y1O) mica (UNII: V8A1AW0880) starch, corn (UNII: O8232NY3SJ) high density polyethylene (UNII: UG00KM4WR7) silica dimethyl silylate (UNII: EU2PSP0G0W) peg/ppg-18/18 dimethicone (UNII: 9H0AO7T794) carnauba wax (UNII: R12CBM0EIZ) kojic dipalmitate (UNII: 13N249RWTM) polyglyceryl-4 isostearate (UNII: 820DPX33S7) hexyl laurate (UNII: 4CG9F9W01Q) phenoxyethanol (UNII: HIE492ZZ3T) triethoxycaprylylsilane (UNII: LDC331P08E) caprylyl glycol (UNII: 00YIU5438U) chlorphenesin (UNII: I670DAL4SZ) licorice (UNII: 61ZBX54883) dimethylmethoxy chromanyl palmitate (UNII: 5G222ZDK7U) .beta.-citronellol, (R)- (UNII: P01OUT964K) butylphenyl methylpropional (UNII: T7540GJV69) hydroxycitronellal (UNII: 8SQ0VA4YUR) .alpha.-hexylcinnamaldehyde (UNII: 7X6O37OK2I) limonene, (+)- (UNII: GFD7C86Q1W) hydroxyisohexyl 3-cyclohexene carboxaldehyde (UNII: QUE43B9Z2Q) isomethyl-.alpha.-ionone (UNII: 9XP4LC555B) titanium dioxide (UNII: 15FIX9V2JP) ferric oxide red (UNII: 1K09F3G675) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:14783-220-02 1 in 1 BOX 12/26/2018 1 NDC:14783-220-01 9 g in 1 CONTAINER; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 12/26/2018 LBEL CLARITE CLARIFYING EFFECT FOUNDATION SPF 30 CLAIRE 8/BEIGE
octinoxate and zinc oxide liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:14783-221 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 0.075 g in 1 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 0.0784 g in 1 g Inactive Ingredients Ingredient Name Strength Dimethicone (UNII: 92RU3N3Y1O) mica (UNII: V8A1AW0880) starch, corn (UNII: O8232NY3SJ) high density polyethylene (UNII: UG00KM4WR7) silica dimethyl silylate (UNII: EU2PSP0G0W) peg/ppg-18/18 dimethicone (UNII: 9H0AO7T794) carnauba wax (UNII: R12CBM0EIZ) kojic dipalmitate (UNII: 13N249RWTM) polyglyceryl-4 isostearate (UNII: 820DPX33S7) hexyl laurate (UNII: 4CG9F9W01Q) phenoxyethanol (UNII: HIE492ZZ3T) triethoxycaprylylsilane (UNII: LDC331P08E) caprylyl glycol (UNII: 00YIU5438U) chlorphenesin (UNII: I670DAL4SZ) licorice (UNII: 61ZBX54883) dimethylmethoxy chromanyl palmitate (UNII: 5G222ZDK7U) .beta.-citronellol, (R)- (UNII: P01OUT964K) butylphenyl methylpropional (UNII: T7540GJV69) hydroxycitronellal (UNII: 8SQ0VA4YUR) .alpha.-hexylcinnamaldehyde (UNII: 7X6O37OK2I) limonene, (+)- (UNII: GFD7C86Q1W) hydroxyisohexyl 3-cyclohexene carboxaldehyde (UNII: QUE43B9Z2Q) isomethyl-.alpha.-ionone (UNII: 9XP4LC555B) titanium dioxide (UNII: 15FIX9V2JP) ferric oxide red (UNII: 1K09F3G675) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:14783-221-02 1 in 1 BOX 12/26/2018 1 NDC:14783-221-01 9 g in 1 CONTAINER; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 12/26/2018 LBEL CLARITE CLARIFYING EFFECT FOUNDATION SPF 30 CLAIRE 9/BROWN
octinoxate and zinc oxide liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:14783-216 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 0.075 g in 1 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 0.0784 g in 1 g Inactive Ingredients Ingredient Name Strength Dimethicone (UNII: 92RU3N3Y1O) mica (UNII: V8A1AW0880) starch, corn (UNII: O8232NY3SJ) high density polyethylene (UNII: UG00KM4WR7) silica dimethyl silylate (UNII: EU2PSP0G0W) peg/ppg-18/18 dimethicone (UNII: 9H0AO7T794) carnauba wax (UNII: R12CBM0EIZ) kojic dipalmitate (UNII: 13N249RWTM) polyglyceryl-4 isostearate (UNII: 820DPX33S7) hexyl laurate (UNII: 4CG9F9W01Q) phenoxyethanol (UNII: HIE492ZZ3T) triethoxycaprylylsilane (UNII: LDC331P08E) caprylyl glycol (UNII: 00YIU5438U) chlorphenesin (UNII: I670DAL4SZ) licorice (UNII: 61ZBX54883) dimethylmethoxy chromanyl palmitate (UNII: 5G222ZDK7U) .beta.-citronellol, (R)- (UNII: P01OUT964K) butylphenyl methylpropional (UNII: T7540GJV69) hydroxycitronellal (UNII: 8SQ0VA4YUR) .alpha.-hexylcinnamaldehyde (UNII: 7X6O37OK2I) limonene, (+)- (UNII: GFD7C86Q1W) hydroxyisohexyl 3-cyclohexene carboxaldehyde (UNII: QUE43B9Z2Q) isomethyl-.alpha.-ionone (UNII: 9XP4LC555B) titanium dioxide (UNII: 15FIX9V2JP) ferric oxide red (UNII: 1K09F3G675) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:14783-216-02 1 in 1 BOX 12/26/2018 1 NDC:14783-216-01 9 g in 1 CONTAINER; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 12/26/2018 Labeler - Ventura International LTD (603192787) Establishment Name Address ID/FEI Business Operations Bel Star S.A. (Colombia) 880160197 MANUFACTURE(14783-213, 14783-214, 14783-215, 14783-217, 14783-218, 14783-219, 14783-220, 14783-221, 14783-216)